BIRC5 and neoplasm: Mesri et al [21] reported increased mitochondrial release of cytochrome C and caspase-3 activity and increased apoptosis in tumor cells, after mutation of threonine 34 (Thr34) phosphorylation site of survivin in breast, cervical, prostate, lung, and colorectal cancer cell lines.